This company seems to have been delisted
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Heska Corporation
HSKA
S$154.49
Share price
0.00%
Change (1 day)
24.55%
Change (1 year)
Categories
Heska Corporation (HSKA) - Total debt
Total debt on the balance sheet as of March 2023 : S$0.14 Billion
According to Heska Corporation 's latest financial reports the company's total debt is S$0.14 Billion. A company’s total debt is the sum of all current and non-current debts.
Heska Corporation - Total debt on balance sheet (from 1997 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | S$0.13 B | -3.28% |
| 2021-12-31 | S$0.14 B | 96.48% |
| 2020-12-31 | S$72.7 M | 2.47% |
| 2019-12-31 | S$70.95 M | 761.13% |
| 2018-12-31 | S$8.23 M | 2.67% |
| 2017-12-31 | S$8.02 M | 639.31% |
| 2016-12-31 | S$1.08 M | 106.84% |
| 2015-12-31 | S$0.52 M | -4.53% |
| 2014-12-31 | S$0.54 M | -91.81% |
| 2013-12-31 | S$6.71 M | 115.13% |
| 2012-12-31 | S$3.12 M | |
| 2010-12-31 | S$3.96 M | -38.34% |
| 2009-12-31 | S$6.43 M | -63.11% |
| 2008-12-31 | S$17.43 M | -16.67% |
| 2007-12-31 | S$20.92 M | 21.58% |
| 2006-12-31 | S$17.21 M | -22.97% |
| 2005-12-31 | S$22.34 M | 12.78% |
| 2004-12-31 | S$19.81 M | 15.94% |
| 2003-12-31 | S$17.08 M | -8% |
| 2002-12-31 | S$18.57 M | 15.84% |
| 2001-12-31 | S$16.03 M | 86.74% |
| 2000-12-31 | S$8.58 M | -61.23% |
| 1999-12-31 | S$22.14 M | -28.66% |
| 1998-12-31 | S$31.03 M | 30.57% |
| 1997-12-31 | S$23.77 M | 198.01% |
| 1996-12-31 | S$7.97 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | S$1.36 B | 868.05% | 🇺🇸 USA |
 Eli Lilly LLY | S$49.59 B | 35,096.19% | 🇺🇸 USA |
 Petco WOOF | S$3.76 B | 2,572.42% | 🇺🇸 USA |
 Pfizer PFE | S$78.91 B | 55,908.30% | 🇺🇸 USA |
 Merck MRK | S$44.86 B | 31,740.78% | 🇺🇸 USA |
 Novartis NVS | S$40.26 B | 28,474.82% | 🇨🇭 Switzerland |
 Zoetis ZTS | S$8.69 B | 6,068.21% | 🇺🇸 USA |